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Summary
A 77-year-old woman without traditional risk factors for
coronary artery disease (CAD) underwent coronary CTangiography for evaluation of palpitations after negative
Holter monitoring and non-diagnostic ECG exercise
stress test. Coronary artery calcium score was reported
zero; 1 day later, she was admitted with anteriorwall ST elevation myocardial infarction. Acute left
anterior descending artery thrombus was treated with
mechanical thrombectomy and Percutaneous Coronary
Intervention (PCI). Interestingly, the coronary arteries
were angiographically normal. During hospitalisation,
paroxysmal atrial fibrillation was noted followed by
initiation of anticoagulation. Echocardiogram did not
show thrombus or atrial shunt. Cardioversion with
Sotalol was successful. Myocardial infraction was
most likely cardioembolic secondary to paroxysmal
atrial fibrillation—consistent with longstanding
history of palpitations. Accounting for 3% of acute
coronary syndromes, coronary embolism is treated
with therapeutic anticoagulation for at least 3 months
irrespective of cause and carries a higher risk of adverse
cardiovascular events.

Background

Estimated 3% of acute coronary syndromes (ACS)
are caused by coronary embolism (CE). In patients
with ACS without significant underlying coronary
artery disease (CAD), embolic aetiology should
be considered. Diagnosis of CE may be difficult
in patients with paroxysmal atrial fibrillation, as
the rhythm may be normal at presentation. Identification of CE subgroup of patients with ACS
is important because of increased risk for major
adverse cardiac outcomes and importance of
systemic anticoagulation in prevention of future
embolic events.
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A 77-year-old non-smoker woman presented with
sudden onset substernal chest pain radiating to the
left arm. ECG showed anterior wall ST-elevation
myocardial infarction (STEMI). Haemodynamically
stable, emergent cardiac catheterisation revealed a
100% acute occlusion of the proximal left anterior descending artery (LAD, figure 1A). Left main,
circumflex and right coronary arteries were normal
(0% stenosis reported); no circumflex-LAD or right
coronary artery (RCA)–LAD collaterals were noted.
Mechanical thrombectomy was performed followed

1,2

by the placement of two stents in the proximal LAD.
Guideline-directed post-STEMI medical therapy
was initiated: aspirin, clopidogrel, beta-adrenergic
antagonist, statin and ACE inhibitor.
Few weeks prior to her presentation with STEMI,
the patient was seen in outpatient cardiology office
for daily symptoms of palpitations and progressive
exertional dyspnoea. According to the patient, her
heartbeat has ‘felt irregular’ for several years. No
prior history of hypertension, diabetes mellitus,
dyslipidemia, atrial fibrillation or cardiovascular
disease was reported. At the office visit, 12-lead
ECG was sinus rhythm with premature ventricular complexes (PVCs). 24 hours Holter monitor
was notable for sinus rhythm with premature atrial
contractions (2.1% of beats) and PVCs (1.2% of
beats). The patient then underwent an ECG stress
test with non-diagnostic ST and T wave changes.
Given the non-diagnostic stress test and atypical symptoms, 1 day prior to her presentation with
STEMI, a coronary CT angiogram was performed
which revealed a coronary artery calcium (CAC)
score of zero and no CAD whatsoever.

Investigations

1. Troponin 10.38 ng/mL (reference: <0.05 ng/
mL).
2. Fasting lipid panel—low density lipoprotein
(LDL) 118 mg/dL; total cholesterol 202 mg/dL
(reference: <200 mg/dL); triglycerides 100 mg/
dL (reference: <150 mg/dL); high density lipoprotein (HDL) 64 mg/dL (reference: >35 mg/
dL).
3. Fasting serum glucose 100 mg/dL.
4. Transthoracic ECHO: Left ventricular ejection
fraction 35%–39% with segmental wall motion
abnormalities. Normal-sized left and right atria.
No mitral stenosis or aortic valve abnormality.
No patent foramen ovale.
5. Echocardiographic evaluation was negative for
an inter-atrial communication or cardiac masses.
6. No inter-atrial communication was detected by
the right heart catheterisation.

Differential diagnosis

Given the normal coronary arteries on computed
tomography angiography (CTA) followed by LAD
occlusion with high clot burden, investigation for
non-atherosclerotic embolic causes ensued. There
was no history of hypercoagulable state, and the
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Discussion

Figure 2 Atrial fibrillation on 12-lead ECG.

Causes of CE are broadly divided into three categories: direct,
paradoxical and iatrogenic.1 In causes classified as direct, the
embolus originates from a thrombus in the left atrium and
ventricle, mitral and aortic valves, pulmonary veins or proximal
coronary artery—with paroxysmal or persistent atrial fibrillation
being the most common cause (73%).2 Other direct aetiologies
of CE due to the left-sided thrombus include endocarditis and
post-myocardial infraction left ventricular thrombus.1 Paradoxical CE may also be secondary to venous thrombi entering
the systemic circulation through an atrial septal defect, patent
foramen ovale or pulmonary arteriovenous malformation.1
When compared with the cerebral and systemic circulation,
the coronary arterial vasculature is relatively protected from
emboli because of difference in calibre of the aorta and main
coronary arteries, the acute angle at which the coronaries originate from the aorta, and the fast flow across the coronary ostia.1
Consequently, CE is a rare cause of ACS overall (2.9%) and
STEMI (4.3%).2 3
Clinical presentation of acute myocardial infarction due to CE
is indistinguishable from atherosclerotic myocardial infarction.1
Consequently, the initial ACS management is the same, regardless of the aetiology. However, recognition of CE, in addition to
specific medical management, is important because of the need
for closer monitoring in this subpopulation and increased risk of
cardiac death as compared with the patients with atherosclerotic
myocardial infarction.3Patients with CE myocardial infarction
suffer from significantly increased 5-year risk of adverse cardiac
and cerebrovascular events, which may be as high as 27%.2 Age
greater than 60 years, female gender, reduced left ventricular
ejection fraction and atrial fibrillation are independent risk
factors for major adverse cardiovascular events in patients with
non-atherosclerotic myocardial infarction,4 emphasising the
importance of recognising CE and associated prognostic factors.
CE diagnosis may be suspected on retrospective evaluation
of coronary angiogram when the occlusive thrombus burden is
disproportionate to the degree of atherosclerosis, no or minimal
atherosclerosis in other coronary territories, or there is evidence
of concomitant systemic embolisation in other arterial beds, for
example, cerebral, mesenteric, retinal or in extremities.2Compared with those patients with atherosclerotic CAD, patients
with CE are less likely to have traditional risk factors—hypertension, dyslipidemia, smoking and diabetes.5 However, it may
reflect a selection bias, as more thorough search for embolic
source is performed in patients with ACS without significant
risk factors for systemic atherosclerosis. Anticoagulation is the
treatment of choice for all patients with CE, and thrombophilia
testing is not routinely indicated.1 However, decision for testing
needs to be individualised, for instance to determine duration of
treatment in patients with unexplained venous thromboembolism and/or who are at higher risk for bleeding.
Major CE diagnostic criteria (suggested by Shibata et al2)
include (1) angiographic findings of coronary vessel occlusion
without atherosclerosis; (2) concomitant involvement of multiple
coronary territories and/or distal systemic embolism; (3) histologic evidence of venous thrombus and (4) echocardiographic/
CT/MRI evidence of intracardiac thrombus. Minor criteria
include (1) <25% stenosis of non-culprit coronary vessels, (2)
known atrial fibrillation and (3) risk factor for embolism (eg,
patent foramen ovale, atrial septal defect, dilated cardiomyopathy, prosthetic valve, etc.). Our patient met one major criterion
(angiographic evidence of large thrombus without significant
underlying atherosclerosis, figure 1B) and two minor criteria
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Figure 1 (A) Left anterior oblique (LAO) caudal view of proximal
left anterior descending artery (LAD) occlusion (arrow). (B) Right
anterior oblique (RAO) cranial view of non-diseased LAD (arrow) postthrombectomy and Percutaneous Coronary Intervention (PCI).
patient denied miscarriages or arterial/venous thrombosis. Likewise, no history of atrial septal defect, endocarditis or recent/
remote cardiac intervention was reported. Transthoracic echocardiogram was unrevealing for an intracardiac shunt, thrombus
or mass. Despite extensive discussion and explanation of the
diagnostic and therapeutic benefit, the patient declined transoesophageal echocardiography. Extended ambulatory rhythm
monitoring was planned but on the second day of hospitalisation, paroxysmal atrial fibrillation was recorded on telemetry
(figure 2).

Treatment

Systemic oral anticoagulation was initiated (Apixaban 5 mg two
times per day) followed by successful pharmacologic cardioversion with Sotalol. Dual antiplatelet (aspirin and clopidogrel) and
post-STEMI guideline-directed medical therapy were continued,
including high intensity statin and ACE inhibitor, but metoprolol
was replaced by Sotalol.

Outcome and follow-up

The patient was discharged after unremarkable 72 hours monitoring for QTc prolongation post-initiation of Sotalol. Triple
therapy with aspirin, clopidogrel and apixaban was continued
at discharge with the intent to discontinue aspirin after 6 weeks
to minimise bleeding risk. No chest pain, exertional dyspnoea
or heart failure symptoms were reported at 1 week follow-up.
The patient’s ECG showed normal sinus rhythm with resolving
ST-elevations. Ejection fraction was preserved on repeat transthoracic ECHO. Monthly appointments are scheduled for close
monitoring and observation for bleeding on long-term anticoagulation (CHA2DS2VASc score=5) and clopidogrel.
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(atrial fibrillation and <25% stenosis in non-culprit vessels)
qualifying as definite CE.2
There was no significant coronary atherosclerosis by invasive angiogram in the acute setting. Moreover, a coronary
CTA performed just 1 day prior to the STEMI presentation
did not reveal any evidence for atherosclerotic disease whatsoever. False-negative results of CT coronary angiography do
occur with reported negative predictive values of 80%–90%.6
However, these false-negative results typically occur in patients
with atherosclerotic disease in whom a particular intracoronary
lesion is ‘undercalled’ by the reader. In the case presented, the
CAC score of 0 and finding of no non-calcified plaque make a
false-negative CT result very unlikely. Finally, in some patients,
myocardial infarction may cause atrial fibrillation.7 But our
patient had longstanding history of palpitations which, in retrospect, were probably due to undiagnosed paroxysmal atrial
fibrillation. In suspected embolic infarct, post-thrombectomy
intravascular ultrasound would have been useful in ruling out
dissection or eroded plaque and, in the presence of normal vessel
morphology, would have confirmed the diagnosis of embolism.8
In confirmed embolic myocardial infarction, it would have obviated the need for triple antithrombotic therapy (dual antiplatelet
and anticoagulation).
The chronology of events in the presented case serves as a
reminder of the clinical characteristics associated with CE, its
diagnostic evaluation and treatment to reduce risk of recurrence.
Although there are no formal guidelines for management of CE,
workup should include extended cardiac rhythm monitoring for
detection of paroxysmal or persistent atrial fibrillation (the most
common cause of CE) and transoesophageal echocardiography
for detection of left atrial thrombus and right-to-left shunt. In
retrospect, delayed enhancement cardiac MRI could have been
offered as an alternative to transoesophageal echocardiography
for left atrial thrombus detection.9
The recommended treatment for CE is systemic anticoagulation. The duration of anticoagulation in CE due to paradoxical
right-to-left embolism depends on the underlying thrombosis
aetiology and risk-profile, with treatment duration of 3 months
if risk factors are transient, or longer if persistent.1 As in the
presented patient, if atrial fibrillation is detected (CHA2DS2VASc assigned to a minimum of two in men and three in
women with CE), long-term anticoagulation is indicated. Additional complexity of patient care and increased bleeding risk
due to dual antiplatelet therapy and systemic anticoagulation
should be considered as well. In patients with increased bleeding
risk on dual antiplatelet therapy who require systemic anticoagulation, aspirin may be stopped 4 weeks after the acute event
with acceptable long-term outcomes.7 Thrombectomy and longterm anticoagulation are adequate therapy for CE secondary to
atrial fibrillation. The role of left atrial appendage closure for
prevention of the CE events in patients with atrial fibrillation is
currently unclear. This case highlights the benefit of evaluating
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suspected CE with intravascular ultrasound or optical coherence
tomography post-thrombectomy to avoid unnecessary percutaneous coronary intervention and bleeding risk associated with
triple antithrombotic therapy.

Learning points
►► Coronary embolism (CE) is an under-recognised cause of

acute coronary syndrome associated with worse cardiac and
cerebrovascular outcomes compared with atherosclerotic
heart disease.
►► Atrial fibrillation is the most common cause of CE. Longterm rhythm monitoring for detection of atrial fibrillation is
indicated.
►► Thrombophilia testing is not routinely indicated in CE except
for unexplained venous thrombosis.
►► Increased bleeding risk due to dual antiplatelet therapy and
systemic anticoagulation should be considered. Evaluation
of suspected CE with post-thrombectomy intravascular
ultrasound may prevent unnecessary percutaneous coronary
intervention and bleeding risk associated with triple
antithrombotic therapy.
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